Ironwood Investment Counsel’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.57M | Sell |
21,624
-771
| -3% | -$166K | 0.66% | 48 |
|
|
2025
Q4 | $4.6M | Sell |
22,395
-2,823
| -11% | -$531K | 0.64% | 47 |
|
|
2025
Q3 | $3.96M | Sell |
25,218
-6,447
| -20% | -$996K | 0.58% | 53 |
|
|
2025
Q2 | $5.32M | Sell |
31,665
-3,053
| -9% | -$453K | 0.82% | 37 |
|
|
2025
Q1 | $4.78M | Sell |
34,718
-1,406
| -4% | -$179K | 0.83% | 37 |
|
|
2024
Q4 | $4.27M | Sell |
36,124
-941
| -3% | -$110K | 0.73% | 41 |
|
|
2024
Q3 | $4.1M | Sell |
37,065
-163
| -0.4% | -$17K | 0.68% | 44 |
|
|
2024
Q2 | $3.66M | Sell |
37,228
-591
| -2% | -$60.2K | 0.65% | 46 |
|
|
2024
Q1 | $4.23M | Sell |
37,819
-252
| -0.7% | -$27.2K | 0.74% | 43 |
|
|
2023
Q4 | $3.84M | Sell |
38,071
-607
| -2% | -$60.2K | 0.72% | 42 |
|
|
2023
Q3 | $3.36M | Sell |
38,678
-1,474
| -4% | -$133K | 0.71% | 42 |
|
|
2023
Q2 | $3.8M | Sell |
40,152
-1,830
| -4% | -$155K | 0.85% | 40 |
|
|
2023
Q1 | $3.17M | Sell |
41,982
-960
| -2% | -$72.4K | 0.75% | 44 |
|
|
2022
Q4 | $3.3M | Buy |
42,942
+383
| +0.9% | +$29.1K | 0.8% | 46 |
|
|
2022
Q3 | $2.84M | Buy |
42,559
+549
| +1% | +$34.8K | 0.81% | 41 |
|
|
2022
Q2 | $2.19M | Buy |
42,010
+2,529
| +6% | +$144K | 0.62% | 49 |
|
|
2022
Q1 | $2.24M | Buy |
39,481
+3,132
| +9% | +$168K | 0.55% | 55 |
|
|
2021
Q4 | $1.87M | Sell |
36,349
-430
| -1% | -$21.1K | 0.43% | 60 |
|
|
2021
Q3 | $1.82M | Buy |
36,779
+4,648
| +14% | +$252K | 0.47% | 58 |
|
|
2021
Q2 | $1.83M | Buy |
32,131
+7,235
| +29% | +$423K | 0.49% | 61 |
|
|
2021
Q1 | $1.51M | Sell |
24,896
-4,919
| -16% | -$272K | 0.43% | 61 |
|
|
2020
Q4 | $1.6M | Buy |
29,815
+1,103
| +4% | +$57.2K | 0.36% | 65 |
|
|
2020
Q3 | $1.35M | Buy |
28,712
+1,097
| +4% | +$56.3K | 0.36% | 68 |
|
|
2020
Q2 | $1.44M | Sell |
27,615
-2,622
| -9% | -$135K | 0.44% | 61 |
|
|
2020
Q1 | $1.45M | Buy |
30,237
+1,978
| +7% | +$103K | 0.57% | 55 |
|
|
2019
Q4 | $1.43M | Buy |
28,259
+773
| +3% | +$39.9K | 0.49% | 58 |
|
|
2019
Q3 | $1.3M | Buy |
27,486
+1,944
| +8% | +$88.7K | 0.48% | 59 |
|
|
2019
Q2 | $1.2M | Buy |
25,542
+3,142
| +14% | +$145K | 0.46% | 62 |
|
|
2019
Q1 | $1.08M | Buy |
22,400
+728
| +3% | +$36.5K | 0.42% | 66 |
|
|
2018
Q4 | $966K | Buy |
21,672
+1,748
| +9% | +$91.1K | 0.42% | 64 |
|
|
2018
Q3 | $1.07M | Buy |
19,924
+2,472
| +14% | +$127K | 0.42% | 64 |
|
|
2018
Q2 | $852K | Buy |
+17,452
| New | +$990K | 0.37% | 68 |
|
Other funds holding CAH
VCM
VPM
Ironwood Investment Counsel's CAH Position: Q1 2026 in Review
Ironwood Investment Counsel reduced its Cardinal Health (CAH) stake by 3.4% in Q1 2026, selling an estimated $166K and leaving 21,624 shares worth $4.57M. The position accounts for 0.66% of the portfolio, ranked #48.
Ironwood Investment Counsel first reported a position in CAH in Q2 2018 and has held it in 32 quarters since. The position peaked at $5.32M in Q2 2025. 1,426 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Ironwood Investment Counsel held 21,624 shares of Cardinal Health worth $4.57M as of Q1 2026.
- Ironwood Investment Counsel sold 771 Cardinal Health shares in Q1 2026, an estimated $166K.
- Cardinal Health made up 0.66% of Ironwood Investment Counsel's portfolio in Q1 2026, its #48 holding.
- Ironwood Investment Counsel first reported a position in Cardinal Health in Q2 2018 and has held it in 32 quarters since.
- Ironwood Investment Counsel's Cardinal Health position peaked at $5.32M in Q2 2025.
- 1,426 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Ironwood Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.